Stocktoria

ARTELO BIOSCIENCES, INC. ARTL

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-10-13

ARTELO BIOSCIENCES, INC. statistics & valuation

Market cap$3.9M

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2017201820192020202120212022202320242025
Operating margin (%)
2017201820192020202120212022202320242025
Return on equity (%)
-43.10% -39.80% -120.10% -61.80% -34.60% -52.00% -79.00% -343.90% 2017201820192020202120212022202320242025
Shares outstanding
11.3M 1.8M 3.4M 5.0M 1.6M 2.8M 2.9M 3.2M 567582 1.0M 2017201820192020202120212022202320242025
Net debt ($)
2017201820192020202120212022202320242025
Share buybacks ($)
2017201820192020202120212022202320242025
Return on assets (%)
-40.90% -590.30% -33.50% -106.40% -58.90% -33.30% -49.40% -71.20% -209.20% -459.80% 2017201820192020202120212022202320242025
Free cash flow margin (%)
2017201820192020202120212022202320242025
Debt / equity (×)
2017201820192020202120212022202320242025
EPS ($)
-$1.84 -$1.46 -$3.14 -$18.30 -$12.52 2017201820192020202120212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2021FY2020FY2019FY2018FY2017
Return on assets-459.8%-209.2%-71.2%-49.4%-33.3%-58.9%-106.4%-33.5%-590.3%-40.9%
Return on equity1012.5%-343.9%-79.0%-52.0%-34.6%-61.8%-120.1%-39.8%1736.3%-43.1%
Current ratio0.171.448.5118.3623.9619.614.664.350.7519.51

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.